Neuroscientific Biopharmaceuticals Ltd: Appendix 4G & Corporate Governance Statement
Neuroscientific Biopharmaceuticals Ltd: Quarterly Activities/Appendix 4C Cash Flow Report
Neuroscientific Biopharmaceuticals Ltd: Notice of Release of Escrowed Securities
Neuroscientific Biopharmaceuticals Ltd: NSB Completes PRE-IND Meeting with US FDA on EmtinB
Neuroscientific Biopharmaceuticals Ltd: Quarterly Activities/Appendix 4C Cash Flow Report
Neuroscientific Biopharmaceuticals Ltd: NSB Receives A$2.2M Research & Development Tax Refund
Neuroscientific Biopharmaceuticals Ltd: Quarterly Activities/Appendix 4C Cash Flow Report
Neuroscientific Biopharmaceuticals Ltd: Expiry of Options
Neuroscientific Biopharmaceuticals Ltd: Final Director's Interest Notice - Rennie
Neuroscientific Biopharmaceuticals Ltd: Final Director's Interest Notice - Quantrill
Neuroscientific Biopharmaceuticals Ltd: Initial Director's Interest Notice - Keating
Neuroscientific Biopharmaceuticals Ltd: Notice of Annual General Meeting - Withdrawal of Resolutions
Neuroscientific Biopharmaceuticals Ltd: Initial Director's Interest Notice - Barlow
Neuroscientific Biopharmaceuticals Ltd: Initial Director's Interest Notice - Ntoumenopoulos
Neuroscientific Biopharmaceuticals Ltd: Investor Update Webinar
Neuroscientific Biopharmaceuticals Ltd: Quarterly Activities/Appendix 4C Cash Flow Report
Neuroscientific Biopharmaceuticals Ltd: Date of AGM & Closing Date for Director Nominations
Neuroscientific Biopharmaceuticals Ltd: Appendix 4G
Neuroscientific Biopharmaceuticals Ltd: Corporate Governance Statement
Neuroscientific Biopharmaceuticals Ltd: Expiry of Performance Shares
No Data
No Data